Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.245 USD | -2.88% | +1.38% | -28.79% |
Mar. 27 | MiMedx Group Says FDA Affirms Axiofill Falls Short of Regulatory Standards for Tissue-Based Products | MT |
Mar. 27 | MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.79% | 949M | |
-20.09% | 131M | |
-16.12% | 61.96M | |
+7.05% | 60.9M | |
+0.60% | 52.2M |
- Stock Market
- Equities
- MDXG Stock
- News MiMedx Group, Inc.
- MiMedx : HC Wainwright Starts MiMedx Group at Buy With $20 Price Target